Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,500 | 2 | 80.2% |
| Travel and Lodging | $1,082 | 1 | 13.3% |
| Food and Beverage | $496.19 | 7 | 6.1% |
| Education | $29.00 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lumendi LLC | $7,735 | 5 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $225.18 | 3 | $0 (2019) |
| Ethicon US, LLC | $100.52 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $29.00 | 2 | $0 (2018) |
| Actelion Pharmaceuticals US, Inc. | $17.67 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $100.52 | 1 | Ethicon US, LLC ($100.52) |
| 2020 | $17.67 | 1 | Actelion Pharmaceuticals US, Inc. ($17.67) |
| 2019 | $225.18 | 3 | Janssen Pharmaceuticals, Inc ($225.18) |
| 2018 | $2,147 | 4 | Lumendi LLC ($2,118) |
| 2017 | $5,617 | 3 | Lumendi LLC ($5,617) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/15/2022 | Ethicon US, LLC | Enseal (Device), STRATAFIX | Food and Beverage | In-kind items and services | $100.52 | General |
| Category: Energy | ||||||
| 01/15/2020 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Cardiology | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $104.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/12/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/09/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $114.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 05/30/2018 | Alexion Pharmaceuticals, Inc. | Kanuma (Drug) | Education | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 05/23/2018 | Lumendi LLC | DiLumen (Device) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Gastroenterology | ||||||
| 05/18/2018 | Lumendi LLC | DiLumen (Device) | Food and Beverage | In-kind items and services | $118.03 | General |
| Category: Gastroenterology | ||||||
| 11/14/2017 | Lumendi LLC | DiLumen (Device) | Consulting Fee | Cash or cash equivalent | $4,500.00 | General |
| Category: Gastroenterology | ||||||
| 11/14/2017 | Lumendi LLC | DiLumen (Device) | Travel and Lodging | Cash or cash equivalent | $1,081.88 | General |
| Category: Gastroenterology | ||||||
| 11/04/2017 | Lumendi LLC | DiLumen (Device) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 767 | 825 | $286,946 | $152,880 |
| 2022 | 15 | 714 | 823 | $240,113 | $134,553 |
| 2021 | 19 | 791 | 962 | $231,747 | $143,361 |
| 2020 | 18 | 752 | 910 | $163,296 | $99,344 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 135 | 137 | $88,974 | $61,664 | 69.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 167 | 168 | $95,427 | $35,065 | 36.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 60 | 62 | $32,035 | $16,160 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 122 | $19,224 | $12,986 | 67.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 16 | 16 | $6,670 | $5,515 | 82.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $6,278 | $4,467 | 71.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $5,917 | $3,887 | 65.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 16 | 16 | $8,884 | $3,850 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 48 | $5,260 | $3,635 | 69.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 23 | 23 | $5,181 | $3,475 | 67.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $5,566 | $966.66 | 17.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 26 | 34 | $359.04 | $351.90 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 29 | 36 | $337.38 | $296.94 | 88.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 26 | 36 | $326.95 | $273.96 | 83.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $6,397 | $181.83 | 2.8% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2023 | 12 | 12 | $62.16 | $60.96 | 98.1% |
| 85652 | Red blood cell sedimentation rate, to detect inflammation, automated | Office | 2023 | 15 | 17 | $45.90 | $45.05 | 98.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 109 | 109 | $66,216 | $49,287 | 74.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 93 | 93 | $55,998 | $18,473 | 33.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 51 | 51 | $25,061 | $15,105 | 60.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 101 | $16,414 | $11,173 | 68.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 24 | 24 | $12,373 | $9,498 | 76.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 83 | 90 | $9,999 | $6,622 | 66.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 20 | 21 | $12,013 | $5,048 | 42.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 12 | 12 | $5,259 | $4,983 | 94.8% |
About Dr. Sang Lee, MD
Dr. Sang Lee, MD is a Gastroenterology healthcare provider based in Mount Kisco, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1649474792.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sang Lee, MD has received a total of $8,107 in payments from pharmaceutical and medical device companies, with $100.52 received in 2022. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,500).
As a Medicare-enrolled provider, Lee has provided services to 3,024 Medicare beneficiaries, totaling 3,520 services with total Medicare billing of $530,139. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Mount Kisco, NY
- Active Since 06/13/2007
- Last Updated 11/11/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1649474792
Products in Payments
- DiLumen (Device) $7,735
- INVOKANA (Drug) $225.18
- Enseal (Device) $100.52
- Kanuma (Drug) $29.00
- UPTRAVI (Drug) $17.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.